Fail 46 (2), 2385065
"A lot of doctors don't recognize it with women at all, so here you have all these women on this drug and it's making them healthier, but they're going through this too," she continued
Symptoms requiring healthcare provider contact include: Rash or erythema spreading beyond the injection site or appearing at distant body locations Persistent or worsening symptoms lasting more than 4 to 5 days Significant pain that interferes with movement or daily function Development of pustules, blisters, or skin breakdown Warmth, increasing redness, or red streaking extending from the injection site (potential cellulitis) Fever, chills, or systemic symptoms accompanying local reactions Recurrent severe reactions at multiple injection sites Signs of possible allergic reaction, including hives, facial swelling, or difficulty breathing Call 911 or seek emergency care immediately for signs of severe allergic reaction such as difficulty breathing, throat tightness, severe dizziness, or widespread hives
Without active countermeasures, up to 25% of weight lost can come from muscle rather than fat
The GPx activity was calculated based on the micromoles of GSH consumed during the reaction
Weight loss outcomes from the SURMOUNT trials further illustrate tirzepatide's metabolic impact
